Medication Tapering
Psychiatric medication tapering guided by clinical judgment, continuity, and individualized risk assessment.
Medication tapering at Verigrate refers to the gradual, physician-supervised reduction of psychiatric medications when continued use no longer aligns with clinical response, risk profile, or long-term health. Decisions are informed by the individual’s treatment history, symptom patterns, and tolerance rather than standardized timelines.
Medications Commonly Considered
Evaluation, tapering, and follow-up are conducted by a single physician. This continuity allows for nuanced adjustments, longitudinal assessment, and consistent clinical judgment throughout the tapering process.
Withdrawal phenomena vary by medication class, dose, duration of use, and individual sensitivity, particularly in long-term benzodiazepine use. Common features may include anxiety, sleep disruption, sensory disturbances, and autonomic changes. Careful pacing and monitoring are used to reduce destabilization.